Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant
Journal of Clinical Apheresis · 2023
DOI: 10.1002/jca.22058 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Clinical Apheresis, 2023. Verfasst von Sarika Agarwal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Liver Transplantation, Kidney Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Introduction
Liver transplant is a life‐saving treatment, but due to the limited availability of suitable liver donors, ABO‐incompatible liver transplants (ABOi‐LT) are conducted to increase the availability of liver donors. Perioperative desensitization for ABOi‐LT is an established strategy to circumvent the risk of graft rejection. A single prolonged session can be performed to achieve the desired titers to avoid using multiple immunoadsorption (IA) columns or off‐label reuse of single‐use columns. This study retrospectively assessed the effectiveness of a single prolonged plasmapheresis session using IA as a desensitization strategy in live donor liver transplant (LDLT). Materials and methods This retrospective observational study conducted at a center for liver diseases in North India on six ABOi‐LDLT patients who underwent single prolonged IA sessions in the perioperative period from January 2018 to June 2021.
Results
Median baseline titer in patients was 320 (64, 1024). The median plasma volume adsorbed was 7.5 volumes (4, 8) per procedure, with a mean procedure time of 600 min (310‐753). The reduction in titer ranged from 4 log to 7 log reduction per procedure. Two patients developed transient hypotension during the procedure, which was managed successfully. The median duration of pre‐transplant hospital stay was 1.5 days (1, 3).
Conclusion
Desensitization therapy helps overcome the ABO barrier and decreases the waiting period before a transplant when ABO identical donors are unavailable. A single prolonged IA session reduces the cost of additional IA columns and hospital stay, thus making it a cost‐effective approach to desensitization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
ORCID-Profile: Ashish Maheshwari, Meenu Bajpai
Zitieren
APA
Agarwal, S., Maheshwari, A., & Bajpai, M. (2023). Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22058
Vancouver
Agarwal S, Maheshwari A, Bajpai M. Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant. Journal of Clinical Apheresis. 2023. doi:10.1002/jca.22058
BibTeX
@article{Agarwal2023,
author = {Agarwal, Sarika and Maheshwari, Ashish and Bajpai, Meenu},
title = {Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO ‐incompatible liver transplant},
journal = {Journal of Clinical Apheresis},
year = {2023},
doi = {10.1002/jca.22058}
}
EUVIMED